Imaging markers of incipient dementia: The white matter matters

Neurology

Volumn 79, Issue 8, 2012, Pages 726-727

  Carmichael, Owen T ^a   Salloway, Stephen ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN INJURY; DEMENTIA; DIFFUSION WEIGHTED IMAGING; EDITORIAL; HUMAN; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHITE MATTER;

EID: 84866108952     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182662020     Document Type: Editorial

References (14)

1. de Leeuw F-E, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a populationbased magnetic resonance imaging study: The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70:9-14.
2. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61:1531-1534.
3. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol Aging 2005;26:491-510.
4. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology 2008;71:804-811.
5. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. Circulation 2005;112:1644-1650.
6. Mueller SG, Weiner MW, Thal LJ, et al. Ways toward an early diagnosis in Alzheimer, Äôs disease: The Alzheimer, Äôs Disease Neuroimaging Initiative (ADNI). Alzheimer Dementia 2005;1:55-66.
7. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer, Äôs disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer Dementia 2011;7:280-292.
8. Silbert LC, Dodge HH, Perkins LG, et al. Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology 2012;79:741-747.
9. Zhuang L, Sachdev PS, Trollor JN, et al. Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI. Neurology 2012;79:748-754.
10. Maillard P, Fletcher E, Harvey D, et al. White matter hyperintensity penumbra. Stroke 2011;42:1917-1922.
11. Price CC, Mitchell SM, Brumback B, et al. MRI-leukoaraiosis thresholds and the phenotypic expression of dementia. Neurology 2012;79:734-740.
12. Yoshita M, Fletcher E, Harvey D, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006;67:2192-2198.
13. Desai MK, Mastrangelo MA, Ryan DA, Sudol KL, Narrow WC, Bowers WJ. Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target. Am J Pathol 2010;177:1422-1435.
14. Deoni SC, Mercure E, Blasi A, et al. Mapping infant brain myelination with magnetic resonance imaging. J Neurosci 2011;31:784-791.